Poly Medicure Ltd

  • BSE Code : 531768
  • NSE Symbol : POLYMED
  • ISIN : INE205C01021
  • Industry :HEALTHCARE

up-arrow 1,948.60 10.80(0.56%)

Open Price ()

1,947.90

Prev. Close ()

1,937.80

Volume (No’s)

395,020

Market Cap ()

19,744.33

Low Price ()

1,895.50

High Price ()

1,959.00

 

Book Closure

From Date To Date Announcement
08-Aug-2025 NA Poly Medicure Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2025 inter alia to consider and approve Board Meeting Intimation scheduled to be held on Friday 08th August 2025.
03-Aug-2025 05-Aug-2025 Intimation for Notice of Postal Ballot dated 04th July 2025.
06-May-2025 NA Poly Medicure Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2025 inter alia to consider and approve The Company has informed the Exchange about the Board Meeting scheduled to be held on 06th May 2025 for the purpose of approving the Audited Financial Results (Standalone & Consolidated) for the quarter and year ended 31st March 2025 and also Final Dividend for the Financial Year ended 31st March 2025. Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 06th May, 2025, at 232-B, 3rd Floor, Okhla Industrial Estate, Phase-III, New Delhi-110020, approved the following businesses: a. Audited Financial Results (Consolidate & Standalone) for the Fourth quarter and financial year ended on 31st March 2025. b. Recommendation of Dividend of Rs. 3.50 (Three and half Rupees) per Equity Shares (70%) of Rs. 5 each for the Financial Year 2024-25, subject to the approval of shareholders. c. Appointment of Mr. Vishal Baid, DIN: 00232727 as an Executive Director on board subject to shareholders approval in ensuing General Meeting. d. Mrs. Mukulika Baid, Non Executive Non Independent Director Step Down from the Directorship of the Company. e. Appointment of Auditor(s) (As per BSE Announcement Dated on 06/05/2025)
06-May-2025 NA Audited Standalone & Consolidated Financial Results for the 31.03.2025
31-Mar-2025 NA Recommendation of Dividend of Rs. 3.50 (Three and half Rupees) per Equity Shares (70%) of Rs. 5 each for the Financial Year 2024-25, subject to the approval of shareholders

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew